🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

US LevFin Wrap — MedImpact confronts political pressure, Carlyle weighs Medtronics packages, Alphia goes wide

Share

Market Wrap

US LevFin Wrap — MedImpact confronts political pressure, Carlyle weighs Medtronics packages, Alphia goes wide

Bill Weisbrod's avatar
Emily Fasold's avatar
  1. Bill Weisbrod
  2. +Emily Fasold
4 min read

High yield spreads are at their highest point of the year and the S&P 500 is down nearly 4% over the past month. Nobody panic! 

Maybe just take a deep breath instead, and put things in perspective. 

“The market is still pretty good, it’s just taking step backwards,” said a leveraged finance banker. “Repricings may get put on hold, but stuff can still get done.”

To that end, there are no new high yield issuances currently in market, according to 9fin’s tracker. Loan deals have been popular (we talked about why loans are in favor over bonds these days in last week’s wrap) thanks to strong buyside demand, but that market is quietening down.

“The market is definitely de-risking,” said a buyside analyst. “There’s just so much uncertainty in the macro picture right now, and it’s not a great environment for deals.”

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks